Skip to content

SOBEN Pharma Station

Active
Private limited companyfounded 1981active for 44 yearsAvenue de la Station 50, 4130 Esneux, BelgiumKBO/BCE: BE 0422.219.026
Summary

SOBEN Pharma Station has been active since 1981 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €42,294 and a net result of €74,051. Equity is shrinking by about 14% per year and would, assuming unchanged policy, indicatively turn negative around financial year 2028. Its solvency ranks better than 17% of 4,978 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.7% (low).

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
6th oldest company in Esneux, Wholesale and retail trade sector1 site
Size
€732,996total assets 2025
Staff
3.7 FTE
Equity
€42,294
Profit
€74,051
Financial health
69 Healthy Checked score 2025
Bankruptcy probabilitywithin 12 months
0.7%
Structure
Parent
ALPHAR ESNEUX · 100%
Accounts 107 days early0 of 3 deeds read
Why 69raises riskEquity €42,294 (5.8% of total assets)Sector: Retail trade (NACE 47)lowers riskFounded in 1981Size: 3.7 FTE, total assets €732,996Show the evidence

Checked score

Score 2025
69 / 100
Healthy
Probability in this band: 0.55% to 1.5%
Financially better than 43% of its sector peers (NACE 47, micro)
Financial strength · tick = 2024
Weak
Solvency 31-5
equity 5.8% of total assets
Liquidity 16-2
short-term debt 73.6% · cash 4.4%
Profitability 81+33
return on assets 10.1%
Bankruptcy probability, 12 months
0.7% Low
0%0.5%1.5%4%10%≥ 25%

About 7 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,224 companies, NACE 47, micro)
Last 24 months 11-2024: 0.9% 12-2024: 0.9%● unchanged vs 11-2024 01-2025: 0.9%● unchanged vs 12-2024 02-2025: 0.9%● unchanged vs 01-2025 03-2025: 0.9%● unchanged vs 02-2025 04-2025: 0.9%● unchanged vs 03-2025highest value 05-2025: 0.9%● unchanged vs 04-2025 06-2025: 0.9%● unchanged vs 05-2025 07-2025: 0.9%● unchanged vs 06-2025 08-2025: 0.9%● unchanged vs 07-2025 09-2025: 0.9%● unchanged vs 08-2025 10-2025: 0.9%● unchanged vs 09-2025 11-2025: 0.9%● unchanged vs 10-2025 12-2025: 0.9%● unchanged vs 11-2025 01-2026: 0.9%● unchanged vs 12-2025 02-2026: 0.9%● unchanged vs 01-2026 03-2026: 0.9%● unchanged vs 02-2026 04-2026: 0.9%● unchanged vs 03-2026 05-2026: 0.7%▼ -0.2 percentage points vs 04-2026lowest value 06-2026: 0.7%● unchanged vs 05-2026lowest value 07-2026: 0.7%● unchanged vs 06-2026lowest value 08-2026: 0.7%● unchanged vs 07-2026lowest value 09-2026: 0.7%● unchanged vs 08-2026lowest value 10-2026: 0.7%● unchanged vs 09-2026lowest value
Credit of up to €2,500 on 30-day terms is acceptable
Liquidity tight (current ratio 1.28, compared with 1.31 in 2024, below the usual 1.5; short-term debt: 73.6% and cash: 4.4% of total assets), and 94.2% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 23% on solvency, 15% on liquidity, 74% on profitability and 62% on growth.

The bankruptcy probability was computed on 18-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Seven signals.
lowers riskraises riskneutral
raises risk · Equity €42,294 (5.8% of total assets)
NBB · annual accounts
raises risk · Sector: Retail trade (NACE 47)
KBO
lowers risk · Founded in 1981
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
lowers risk · Size: 3.7 FTE, total assets €732,996
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 17% of 4978 sector peers (2025).
NBB · sector comparison
Position among 4978 sector peers
Solvency
better than 17%
← weakest strongest →
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025
Equity per financial year
1819202122232425
2018 to 2025 · latest year €42,294
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 15-04-2026, 107 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
107 days early
2024
105 days early
2023
93 days early
2022
75 days early
2021
16 days early
2020
107 days early
2019
10 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 70 days before the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 30 April (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
18-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · full…
  2. Highest result from 2018 to 2025net €74,051 ▲255%
  3. Annual accounts filedfinancial year 2024 · full…

Key points

  • Positive: Result rose in 2025from €20,832 to €74,051 ▲ 255% View
  • Caution: Among the weakest 17% on solvencysector median 36.1% · 4,978 companies 5.8% View
  • Positive: 8 profitable years in a rowprofit 2025: €74,051 8 years View
  • Controlled by ALPHAR ESNEUX 100% View
  • Positive: Filed on time since financial year 2020accounts within the deadline every year 6 years View

By topic

Financials

Financial year
2025
Total assets
€732,996
Profit
€74,051
Solvency
5.8%
Total assets▲ 116%
Net result
20182025
Go to Financials

Timeline

Events
47
Since
1983
Next accounts
by 31-07-2027
  1. 29-04-2024Annual accounts filed
  2. 17-05-2023Annual accounts filed
  3. 15-07-2022Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
09-12-1981
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.